NovaBay Pharmaceuticals to Hold Third Quarter 2017 Conference Call on November 14
November 07 2017 - 6:50AM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a
biopharmaceutical company focusing on commercializing its
prescription Avenova® lid and lash hygiene product for the domestic
eye care market, announces that it will report third quarter 2017
financial results after market close on Tuesday, November 14.
Management will hold an investment community conference call that
day to discuss financial results and provide a Company update.
DATE: Tuesday, November 14 TIME: 4:30 p.m. ET / 1:30
p.m. PT DIAL IN: 800-608-8202 from within the U.S. 702-495-1913
from outside the U.S. Enter conference identification number
3187119
The live call also will be available at
http://novabay.com/investors/events. A replay of the call will be
available beginning two hours after its completion through 11:59
p.m. Pacific time December 14, 2017, by dialing 855-859-2056 from
within the U.S. or 404-537-3406 from outside the U.S. and entering
the conference identification number 3187119. The call will also be
archived at http://novabay.com/investors/events.
About NovaBay Pharmaceuticals, Inc.: Going Beyond
Antibiotics®NovaBay Pharmaceuticals, Inc. is a
biopharmaceutical company focusing on commercializing and
developing its non-antibiotic anti-infective products to address
the unmet therapeutic needs of the global, topical anti-infective
market with its two distinct product categories: the NEUTROX®
family of products and the AGANOCIDE® compounds. The Neutrox family
of products includes AVENOVA® for the eye care market, NEUTROPHASE®
for wound care market, and CELLERX® for the aesthetic dermatology
market. The Aganocide compounds, still under development, have
target applications in the dermatology and urology markets.
Socialize and Stay informed on
NovaBay’s progress:Like us
on FacebookFollow us on TwitterConnect with
NovaBay on LinkedInJoin us
on Google+Visit NovaBay’s Website
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171107005713/en/
NovaBay ContactsFor NovaBay
Avenova purchasing information:Please call us toll free:
1-800-890-0329email: sales@avenova.comwww.Avenova.comorFrom the CompanyJack McGovern,
510-899-8800Chief Financial Officerjmcgovern@novabay.comorInvestor
ContactLHA Investor RelationsJody Cain,
310-691-7100Jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Aug 2024 to Sep 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Sep 2023 to Sep 2024